Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Due to increasing of life expectancy, patients with von Willebrand disease are exposed to age-related pathologies such as cancer or cardiovascular diseases. Management of thrombotic events is challenging given the inherent bleeding risk in von Willebrand disease. Few data are currently available in the literature. The aim of the study is to describe the frequency and nature of arterial and venous thromboembolic events and atrial fibrillation in patients with von Willebrand disease in the West of France. The investigators will perform a retrospective multicenter study conducted in the von Willebrand population of the French West. Von Willebrand adult patients followed in one of the French West medical centers participating in the study, who presented deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia, atrial fibrillation, arteriopathy of the lower limbs, angina will be eligible.

Who May Be Eligible (Plain English)

Who May Qualify: - Von Willebrand disease - Adult - Followed-up in a reference center of West of France (Caen, Brest, Nantes, Rennes, Le Mans, Angers) - Consented to be included in BERHLINGO database - Have presented a thrombotic and/or embolic event or cardiovascular disease including deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia or angina or obliterating arteriopathy of the lower limbs, atrial fibrillation. - Have not expressed their opposition Who Should NOT Join This Trial: - \- Expression of opposition - Acquired von Willebrand syndrome - Patients under legal protection - Minor Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Von Willebrand disease * Adult * Followed-up in a reference center of West of France (Caen, Brest, Nantes, Rennes, Le Mans, Angers) * Consented to be included in BERHLINGO database * Have presented a thrombotic and/or embolic event or cardiovascular disease including deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia or angina or obliterating arteriopathy of the lower limbs, atrial fibrillation. * Have not expressed their opposition Exclusion Criteria: * \- Expression of opposition * Acquired von Willebrand syndrome * Patients under legal protection * Minor

Locations (6)

CHU d'Angers
Angers, France
CHU de Brest
Brest, France
CHU de Caen
Caen, France
CH le MANS
Le Mans, France
CHU de Nantes
Nantes, France
CHU de Rennes
Rennes, France